Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC)

Historical Holders from Q3 2021 to Q3 2025

Symbol
RGC on Nasdaq
CUSIP
G7487R100
Type / Class
Equity / Ordinary Shares, $0.00001 Par Value
Shares outstanding
494M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
692K
Holdings value
$11.8M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
14
Number of buys
13
Number of sells
-2
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Regencell (BVI) Ltd 88.6% +2.79% $137B $133B 438M +3802% Yat-Gai Au Jul 11, 2025

Institutional Holders of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$187K 0
2025 Q2 692K $11.8M +$10.8M $17.04 14
2025 Q1 8.83K $281K +$62.6K $31.88 5
2024 Q4 31.6K $156K +$66.4K $4.94 3
2024 Q3 18.1K $100K +$97.3K $5.55 2
2024 Q2 563 $1.89K -$3.66K $3.36 3
2024 Q1 1.65K $7.44K -$65.9K $4.50 3
2023 Q4 16.3K $171K +$167K $10.50 3
2023 Q3 662 $9.27K +$1.73K $14.00 4
2023 Q2 539 $11.7K -$4.94K $21.70 2
2023 Q1 736 $18.9K -$12K $25.88 4
2022 Q4 1.19K $32.3K -$223K $27.20 3
2022 Q3 8.2K $260K -$9.6K $31.69 5
2022 Q2 8.5K $296K -$146K $34.60 5
2022 Q1 19.8K $424K +$196K $21.41 3
2021 Q4 7.01K $230K -$86K $32.06 2
2021 Q3 14K $316K +$316K $22.63 3